mPEG-PLGA-NH2, MW x 10K, n 5K provides an amine-functionalized biodegradable block copolymer for nanoparticle formulation and bioconjugation research and specifically combines a 10 kDa poly(lactic-co-glycolic acid) (PLGA) block with a 5 kDa methoxy polyethylene glycol (mPEG) chain. Its terminal primary amine supports chemical conjugation, while the amphiphilic structure enables investigations of drug encapsulation and controlled release.
Key Features and Benefits
- 10 kDa PLGA Block: Provides a biodegradable hydrophobic polyester segment specifically for nanoparticle formation, drug encapsulation, and controlled-release formulation research.
- 5 kDa mPEG Block: Introduces a hydrophilic PEG chain that contributes to nanoparticle surface hydration and aqueous dispersion properties.
- Terminal Amine Functionality: Provides a primary amine group for conjugation with compatible activated carboxyl, NHS ester, and other amine-reactive compounds.
- Amphiphilic Structure: Combines hydrophobic PLGA and hydrophilic mPEG segments to support polymeric nanoparticle formation under suitable processing conditions.
- Biodegradable Backbone: Contains hydrolytically degradable ester bonds that specifically support investigations of polymer degradation, matrix erosion, and drug release behavior.
- Defined Block Composition: Features a nominal 2:1 PLGA-to-mPEG molecular weight ratio, providing approximately 33.3% PEG by combined block mass.
- Bioconjugation Versatility: Supports attachment of compatible fluorescent probes, targeting ligands, and other functional molecules through amine-reactive chemistry.
- Controlled-Release Potential: Supports biodegradable polymer matrices for evaluating drug diffusion, polymer hydrolysis, and sustained-release behavior.
- Formulation Flexibility: Accommodates nanoprecipitation, emulsification, and solvent evaporation methods for developing functionalized polymeric nanoparticles.
Applications
- Functionalized Nanoparticle Development: Supports preparation of biodegradable nanoparticles containing PLGA hydrophobic domains and hydrophilic mPEG segments.
- Bioconjugation Research: Enables covalent attachment of compatible functional molecules through reactions involving the terminal primary amine.
- Targeted Drug Delivery Research: Supports conjugation of targeting ligands for investigating receptor interactions and nanoparticle targeting strategies.
- Hydrophobic Drug Encapsulation: Facilitates incorporation of compatible, poorly water-soluble compounds into biodegradable PLGA-based polymer matrices.
- Controlled Drug Release: Supports studies of drug diffusion, polymer degradation, and matrix erosion in sustained-release formulations.
- Fluorescent Nanoparticle Labeling: Enables conjugation with compatible amine-reactive fluorescent dyes for imaging and particle-tracking research.
- Nanoparticle Surface Engineering: Supports investigations of surface functionalization, PEG hydration, protein interactions, and colloidal stability.
- Polymer Degradation Studies: Facilitates characterization of PLGA hydrolysis, molecular weight reduction, and degradation-dependent drug release behavior.
- Biodegradable Biomaterials: Provides a functional polymer building block for developing experimental biodegradable materials and chemically modified delivery systems.
Storage and Handling
- Storage: Store at −20°C in a dry, tightly sealed container, protected from moisture and excessive heat. Follow product-specific storage instructions when available. Minimize humidity exposure to reduce premature PLGA hydrolysis.
- Handling: Handle using clean, dry equipment and dissolve in a compatible solvent, such as dichloromethane, acetone, DMF, or DMSO. Confirm solubility before selecting the formulation method.
- Prepare nanoparticles through nanoprecipitation, emulsification, or solvent evaporation, depending on the desired formulation characteristics. The nominal 2:1 PLGA-to-mPEG ratio provides approximately 33.3% PEG by combined block mass.
- Use the terminal amine for conjugation with compatible NHS esters, activated carboxyl groups, or other amine-reactive compounds. Select reaction conditions that preserve PLGA integrity and minimize unwanted hydrolysis. Confirm amine accessibility and conjugation efficiency using appropriate analytical techniques.
- Evaluate particle size, surface properties, drug loading, and release behavior using suitable characterization methods. Avoid prolonged exposure to moisture, strong acids, and alkaline conditions. Confirm the PLGA lactide-to-glycolide ratio, amine functionality, and polymer specifications before use.
mPEG-PLGA-NH2, MW x 10K, n 5K combines biodegradable PLGA, hydrophilic mPEG, and terminal amine functionality for advanced formulation research and specifically supports functionalized nanoparticle development, ligand conjugation, hydrophobic drug encapsulation, controlled release, and biodegradable biomaterials research.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
